Adapt.io vs Ampliz: Honest Comparison (2026)

Adapt.io vs Ampliz: Which B2B Data Tool Should You Actually Pick?

Adapt.io and Ampliz look similar on paper - both are credit-based B2B data platforms with entry plans at $49/month and $50/month respectively. But they serve fundamentally different buyers, and picking the wrong one wastes months. We've seen teams burn an entire quarter on the wrong tool because the use case split is that clear.

There aren't many detailed Adapt.io vs Ampliz breakdowns out there. Let's fix that.

30-Second Verdict

Adapt.io wins for general B2B prospecting. It's built for broad, everyday outbound list-building, and it's far cheaper on entry-level credit economics - $0.098 per credit on Starter versus Ampliz's $0.50 per credit on Global B2B. It also has far stronger review volume on G2: 2,789 reviews versus Ampliz's 7.

Ampliz wins for healthcare and APAC. If you're selling into hospitals, targeting physicians by NPI code, or need APAC coverage across 16 countries, Ampliz has vertical depth that Adapt doesn't touch.

Side-by-Side Comparison

Prospeo takes database breadth, cost per credit, intent data, integrations, data refresh, and accuracy. Adapt.io takes G2 rating by sheer review volume and starting price transparency. Ampliz takes healthcare.

What Adapt.io Offers

Use this if you need a straightforward B2B prospecting tool with broad coverage and don't want to overpay per contact. Adapt's database covers 150M+ contacts across 30M companies, and in our testing, the Chrome extension is noticeably fast for grabbing contacts while browsing company websites - it's consistently one of the most-praised features on G2.

At $49/month for 500 email credits, you're paying $0.098 per reveal. Reasonable for an SMB or early-stage team running targeted outbound.

The 4.6/5 G2 rating from 2,789 reviews gives you real statistical confidence. That's not a handful of friends leaving stars - it's a meaningful sample. G2's aggregated data also shows a 4-month implementation timeline and 16-month ROI payback, worth factoring in if you need fast time-to-value. One thing we noticed: credit limits are among the most common complaints, and a March 2026 reviewer flagged inconsistent phone and email accuracy. So the volume of reviews cuts both ways - you can actually read the negative patterns.

Skip this if you need intent data (Adapt doesn't offer it), you're prospecting into healthcare verticals, or you burn through credits fast. Compared to ZoomInfo, Adapt is dramatically cheaper but lacks the workflow depth, intent signals, and US database scale that justify ZoomInfo's $15,000-$39,000/year pricing tiers.

If you're building a repeatable outbound motion, these sales prospecting techniques help you get more from any database.

What Ampliz Offers

Ampliz isn't trying to be a general-purpose database, and that's actually its strength.

On the APAC side, its G2 vendor profile positions it as an APAC-focused platform with 400M+ B2B contact records across 16 countries. On the healthcare side, Ampliz claims 4M+ healthcare providers and 2M physicians, with support for identifiers like NPI, NEA, and UPIN, plus specialty filters, prescribing data, and hospital affiliations. They position the healthcare dataset as above 95% accurate.

A Reddit thread mapping vertical GTM data providers specifically calls out Ampliz under the healthcare category - and it's right about the bigger point: generic databases like Apollo can be almost worthless for certain vertical motions. One G2 reviewer praised Ampliz's DACH region data quality, though completeness drops for smaller German companies. So there's some signal beyond APAC and healthcare, but it's inconsistent.

Skip this if you're doing general B2B outbound. The G2 rating sits at 4.2/5 from just 7 reviews - too small to draw any real conclusions about reliability. Reviewers describe the UI as outdated and clumsy, with exporting and refining searches taking more clicks than it should. Data completeness outside healthcare and core APAC markets drops off noticeably. Capterra lists Ampliz's starting price at $100/month, while Ampliz's own pricing page shows $50/month for 100 credits on the Global B2B self-serve plan - so double-check before you commit.

If your main issue is enrichment quality (not just raw volume), compare options in our guide to data enrichment services.

Pricing Breakdown

The math here is stark. Adapt's Starter plan: $49/month / 500 credits = $0.098 per contact. Ampliz's Global B2B plan: $50/month / 100 credits = $0.50 per contact. That's a roughly 5x difference at nearly identical monthly spend, which makes Adapt the clear winner on credit economics for general prospecting.

Even on Ampliz's annual plan ($480/year with 100 credits/month), you're still paying $0.40 per credit. The healthcare plan is custom-priced, so expect to negotiate - but don't expect it to get cheaper per contact. Ampliz does offer a free tier with 10 credits, enough to test the interface but not enough to evaluate data quality seriously.

If your average deal size is modest - say under $8k - you probably don't need either tool's credit structure. Prospeo runs about $0.01 per email with a free tier included, making it 90% cheaper on a per-contact basis. And you're paying for verified data rather than database reveals that bounce. (If you're evaluating other free options, start with these free lead generation tools.)

When to Pick Adapt.io

• You're prospecting across industries, not a single vertical
• You want a tool with strong community validation (2,789 G2 reviews)
• Budget matters and you need more credits per dollar
• You don't need intent data or healthcare-specific fields
• Your team values a solid Chrome extension for quick prospecting

If you're standardizing your stack, it can help to map this against your SDR tools and CRM workflow.

When to Pick Ampliz

• You're selling into healthcare and need physician directories with NPI data
• You're targeting APAC markets specifically across their 16-country footprint
• You need claims data, prescribing patterns, or specialty filtering for pharma/medtech GTM
• You're willing to tolerate a dated UI for vertical-specific depth that generic tools can't match

If you're doing healthcare GTM, your qualification process matters as much as the dataset - use a structured MEDDIC sales qualification approach.

When Neither Tool Is Enough

Look - if your real problem is bounce rates and stale data, neither Adapt nor Ampliz addresses that well. Both leave data refresh timelines undisclosed, which tells you something.

Prospeo delivers 98% email accuracy and 125M+ verified mobiles on a 7-day data refresh cycle where the industry average is six weeks. The free tier gives you 75 emails and 100 Chrome extension credits per month - no contracts, no sales calls. Apollo.io is another popular free-tier alternative, but it lacks both Adapt's credit economics and Ampliz's healthcare depth, and in our experience its email accuracy doesn't hold up at scale.

If you're troubleshooting deliverability, start with email bounce rate benchmarks and fixes before you buy more data.

FAQ

Is Adapt.io better than Ampliz for B2B sales?

For general B2B prospecting, yes. Adapt is far cheaper per credit at entry-level plans ($0.098 vs $0.50) and has 2,789 G2 reviews versus Ampliz's 7, giving you far more confidence in the product. Ampliz wins only if you specifically need healthcare provider data or deep APAC coverage.

What's the cheapest way to get verified B2B contacts?

Adapt is roughly 5x cheaper per credit than Ampliz ($0.098 vs $0.50), but neither verifies data on a disclosed refresh cycle. For teams where accuracy matters more than raw volume, Prospeo's per-email cost drops to roughly $0.01 with 98% verified accuracy and a 7-day refresh - the lowest cost-per-verified-contact among all three.